Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008 Oct;35(5):522-9.
doi: 10.1053/j.seminoncol.2008.07.005.

The half century of clinical trials of the National Surgical Adjuvant Breast And Bowel Project

Affiliations
Review

The half century of clinical trials of the National Surgical Adjuvant Breast And Bowel Project

D Lawrence Wickerham et al. Semin Oncol. 2008 Oct.

Abstract

The supplanting of radical mastectomy by simple mastectomy and then by lumpectomy plus radiation, the use of adjuvant therapy to alter the natural course of breast and colorectal cancer, the use of tamoxifen for the prevention of breast cancer, and the dramatic improvement in survival demonstrated with the use of the monoclonal antibody trastuzumab in women with HER2-positive breast cancer are all the direct results of research that has been carried out over the past 50 years by the National Surgical Adjuvant Breast and Bowel Project (NSABP). This National Cancer Institute-supported clinical cooperative trials group based in Pittsburgh, PA, currently has 200 member institutions and 700 satellite centers located throughout the United States, Canada, Puerto Rico, and Ireland. The NSABP's mandate is to conduct large randomized phase III trials to evaluate therapies designed to improve the treatment and prevention of breast and colorectal cancer. Over the past half century, the NSABP has entered more than 150,000 patients and participants into clinical studies that have changed the treatment of colorectal cancer and have revolutionized the treatment and prevention of breast cancer.

PubMed Disclaimer

Figures

Figure 1
Figure 1
NSABP timetable.
Figure 1
Figure 1
NSABP timetable.

References

    1. Fisher B. Status of adjuvant therapy: Results of the National Surgical Adjuvant Breast Project studies on oophorectomy, postoperative radiation therapy, and chemotherapy. Other comments concerning clinical trials. Cancer. 1971;28:1654–8. - PubMed
    1. Fisher B, Montague E, Redmond C, et al. Comparison of radical mastectomy with alternative treatments for primary breast cancer. A first report of results from a prospective randomized clinical trial. Cancer. 1977;39:2827–39. - PubMed
    1. Fisher B, Jeong J, Anderson S, et al. Twenty-five year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med. 2002;347:567–75. - PubMed
    1. Moxley J, 3rd, Allegra JC, Durant JR, et al. The treatment of primary breast cancer: Management of local disease. National Institutes of Health Consensus Development Conference Statement Online June 5. 1979. [Accessed 2007, July, 26]. pp. 29–30. http://consensus.nih.gov/1979/1979PrimaryBreastCancer015html.htm. - PubMed
    1. Fisher B, Bauer M, Margolese R, et al. Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med. 1985;312:665–73. - PubMed

Publication types